Clinical Trial Update: Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results have been posted for a combination of CRS-207, pembrolizumab, ipilimumab, and tadalafil in metastatic pancreatic cancer. The study, sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CRS-207
• Cialis (tadalafil)
• KEYTRUDA (PEMBROLIZUMAB)
• Yervoy (ipilimumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-01-30